Literature DB >> 24863883

Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.

Guiyun Sohn1, Byung Ho Son, Soo Jung Lee, Eun Young Kang, Sung Hoo Jung, Se-Heon Cho, Seunghee Baek, Yu Ra Lee, Hee Jung Kim, Beom Suk Ko, Jong Won Lee, Sei-Hyun Ahn.   

Abstract

BACKGROUND AND OBJECTIVES: Occult breast cancer (OBC) accounts for 0.3-1.0% of all breast cancers and is a rare presentation of the disease. The present retrospective study examined the overall survival and prognostic factors associated with OBC in Korea.
METHOD: The study included 142 OBC patients identified from the Korean Breast Cancer Society cancer registry from January 1990 to December 2009. All patients had pathologically positive axillary lymph nodes (N1-N3) and pathologically and radiologically negative in-breast lesions (T0/Tx) based on a retrospective review of the database.
RESULTS: No statistically significant differences in overall survival were observed between patients undergoing axillary lymph node dissection (ALND) only (80.8%), breast conserving surgery (BCS) with ALND (98.0%), and mastectomy with ALND (92.5%) with P-value of 0.061. Nodal status was a significant prognostic factor (P = 0.004) on univariate analysis. When compared with T1 patients group, T0/TxN1 patients showed better survival than T1N1 patients (hazard ratio [HR] 0.253; 95% confidence interval, 0.104-0.618; P = 0.003), but T0/TxN2, T0/TxN3 patients showed similar survival to T1N2, T1N3 patients.
CONCLUSIONS: OBC patients treated with ALND only showed comparable outcomes to those undergoing ALND combined with BCS or mastectomy. Nodal status may be an independent predictor of poor outcome in OBC patients.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  axillary lymph node dissection; breast conserving surgery; mastectomy; occult breast cancer; survival

Mesh:

Year:  2014        PMID: 24863883     DOI: 10.1002/jso.23644

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  14 in total

1.  Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+).

Authors:  Damian P McCartan; Emily C Zabor; Monica Morrow; Kimberly J Van Zee; Mahmoud B El-Tamer
Journal:  Ann Surg Oncol       Date:  2017-07-12       Impact factor: 5.344

2.  Treatment for occult breast cancer: A propensity score analysis of the National Cancer Database.

Authors:  Catherine Tsai; Beiqun Zhao; Theresa Chan; Sarah L Blair
Journal:  Am J Surg       Date:  2019-11-11       Impact factor: 2.565

3.  The potential role of carbon nanoparticles-assisted biopsy for sentinel lymph nodes of incidental thyroid carcinoma.

Authors:  Chaojie Zhang; Xinying Li; Zhigong Zhang; Shanshan Lei; Peizhi Fan; Qiang Xiao
Journal:  Gland Surg       Date:  2019-08

4.  Histologic Discordance Between Primary Tumor and Nodal Metastasis in Breast Cancer: Solving a Clinical Conundrum in the Era of Genomics.

Authors:  Nicole K Yun; Jessica A Slostad; Ankur Naqib; Casey Frankenberger; Claudia B Perez; Ritu Ghai; Lydia Usha
Journal:  Oncologist       Date:  2021-09-12

5.  A Case Report of Male Occult Breast Cancer First Manifesting as Axillary Lymph Node Metastasis With Part of Metastatic Mucinous Carcinoma.

Authors:  Mengna He; He Liu; Yuxin Jiang
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

6.  Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database.

Authors:  Byoung Hyuck Kim; Jeanny Kwon; Kyubo Kim
Journal:  Cancer Res Treat       Date:  2017-06-01       Impact factor: 4.679

7.  Axillary lymph node metastasis as the first manifestation of male occult breast cancer: A Case Report.

Authors:  Xinyu Wang; Liwen Fan; Wenxing Yan; Qi Zhang; Shunchao Bao; Ying Wang; Xin Bao; Linlin Liu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

Review 8.  Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review.

Authors:  Ruixin Xu; Jianbin Li; Yingjie Zhang; Hongbiao Jing; Youzhe Zhu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  Application of neoadjuvant chemotherapy in occult breast cancer: Five case reports.

Authors:  Haisong Yang; Ling Li; Mengmeng Zhang; Shiyong Zhang; Shu Xu; Xiaoxia Ma
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

10.  Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study.

Authors:  Li-Ping Ge; Xi-Yu Liu; Yi Xiao; Zong-Chao Gou; Shen Zhao; Yi-Zhou Jiang; Gen-Hong Di
Journal:  Cancer Manag Res       Date:  2018-10-09       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.